logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Primary Hypercholesterolemia

    FiltersReset Filters
    11 results

    • cholestyramine

      (cholestyramine)
      EPIC PHARMA, LLC
      Usage: Cholestyramine for Oral Suspension is indicated as adjunctive therapy to diet for reducing elevated LDL cholesterol in primary hypercholesterolemia. It may also relieve pruritus associated with partial biliary obstruction. It aids in lipid management to reduce cardiovascular risk and can be combined with diet and other therapies.

    • cholestyramine

      (cholestyramine)
      PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
      Usage: Cholestyramine for Oral Suspension is indicated as adjunctive therapy to diet for reducing elevated LDL cholesterol in primary hypercholesterolemia. It may also relieve pruritus due to partial biliary obstruction but is not primarily for hypertriglyceridemia. It's part of a comprehensive risk factor management strategy.

    • cholestyramine

      (cholestyramine)
      EPIC PHARMA, LLC
      Usage: Cholestyramine for Oral Suspension is indicated as adjunctive therapy to diet for reducing elevated LDL cholesterol in patients with primary hypercholesterolemia. It also relieves pruritus associated with partial biliary obstruction, although its effect on serum cholesterol may vary in these cases.

    • cholestyramine

      (Cholestyramine)
      Ajanta Pharma USA Inc.
      Usage: Cholestyramine for oral suspension is indicated as an adjunct to diet for reducing elevated LDL cholesterol in primary hypercholesterolemia patients who need more than dietary changes. It also relieves pruritus due to partial biliary obstruction. Regular monitoring of cholesterol levels is essential during therapy.

    • cholestyramine

      (Cholestyramine)
      Macleods Pharmaceuticals Limited
      Usage: Cholestyramine for oral suspension is indicated as adjunctive therapy to diet for reducing elevated LDL cholesterol in patients with primary hypercholesterolemia. It may also relieve pruritus related to partial biliary obstruction but is not primarily indicated for hypertriglyceridemia. Regular monitoring of serum cholesterol levels is recommended.

    • cholestyramine light

      (cholestyramine light)
      EPIC PHARMA, LLC
      Usage: Cholestyramine for Oral Suspension is indicated as adjunctive therapy to diet for reducing elevated serum cholesterol (LDL) in primary hypercholesterolemia patients. It can also relieve pruritus associated with partial biliary obstruction and may aid in lowering LDL cholesterol in patients with hypertriglyceridemia, but is not primarily indicated for the latter.

    • cholestyramine light

      (cholestyramine light)
      EPIC PHARMA, LLC
      Usage: Cholestyramine for Oral Suspension is indicated as adjunctive therapy to diet for reducing elevated LDL cholesterol in primary hypercholesterolemia and for alleviating pruritus from partial biliary obstruction. It is not first-line for hypertriglyceridemia. Treatment should include dietary therapy and evaluation of secondary causes of hypercholesterolemia.

    • cholestyramine light

      (cholestyramine light)
      PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
      Usage: Cholestyramine for Oral Suspension is indicated as adjunctive therapy to diet for reducing elevated LDL cholesterol in primary hypercholesterolemia. It also relieves pruritus from partial biliary obstruction, although its cholesterol-lowering effects are variable in such patients.

    • fenofibrate

      (fenofibrate)
      Mylan Pharmaceuticals Inc.
      Usage: Fenofibrate tablets are indicated as adjunctive therapy to diet for adults with primary hypercholesterolemia or mixed dyslipidemia, aiming to improve cholesterol levels. They are also used for treating severe hypertriglyceridemia, although their effect on reducing coronary heart disease risks in type 2 diabetes patients remains unproven.

    • fenofibrate

      (fenofibrate)
      Solco Healthcare US, LLC
      Usage: Fenofibrate tablets are indicated as adjunctive therapy to diet for adults with primary hypercholesterolemia, mixed dyslipidemia, or severe hypertriglyceridemia. They help reduce LDL-C, total cholesterol, triglycerides, and Apo B, while increasing HDL-C. They do not reduce coronary heart disease morbidity or mortality in diabetes patients.